{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T17:54:23Z","timestamp":1781805263137,"version":"3.54.5"},"reference-count":20,"publisher":"American Diabetes Association","issue":"2","license":[{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK126373"],"award-info":[{"award-number":["R01DK126373"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK132399"],"award-info":[{"award-number":["R01DK132399"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["TL1DK143270"],"award-info":[{"award-number":["TL1DK143270"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U2CDK114886"],"award-info":[{"award-number":["U2CDK114886"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3,1]]},"DOI":"10.2337\/doci25-0009","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T19:02:27Z","timestamp":1775674947000},"page":"189-192","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":0,"title":["Tipping the Balance: Maximizing Cardiovascular Benefits of Sodium\u2013Glucose Cotransporter 2 Inhibitors in Type 1 Diabetes"],"prefix":"10.2337","volume":"1","author":[{"given":"Elizabeth","family":"Kiernan","sequence":"first","affiliation":[{"name":"Kidney Research Institute and Division of Nephrology, Department of Medicine, University of Washington , Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1571-7592","authenticated-orcid":false,"given":"Ian H.","family":"de Boer","sequence":"additional","affiliation":[{"name":"Kidney Research Institute and Division of Nephrology, Department of Medicine, University of Washington , Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2026,4,8]]},"reference":[{"key":"2026061813270302000_B1","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMra2311526","article-title":"Prevention of cardiovascular disease in type 1 diabetes","volume":"390","author":"Manrique-Acevedo","year":"2024","journal-title":"N Engl J Med"},{"key":"2026061813270302000_B2","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1056\/NEJMoa1608664","article-title":"Mortality and cardiovascular disease in type 1 and type 2 diabetes","volume":"376","author":"Rawshani","year":"2017","journal-title":"N Engl J Med"},{"key":"2026061813270302000_B3","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s11886-022-01763-9","article-title":"Cardiovascular disease in adults with type 1 diabetes: looking beyond glycemic control","volume":"24","author":"Miller","year":"2022","journal-title":"Curr Cardiol Rep"},{"key":"2026061813270302000_B4","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.2337\/db08-1543","article-title":"The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes","volume":"58","author":"Groop","year":"2009","journal-title":"Diabetes"},{"key":"2026061813270302000_B5","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/jama.2023.17002","article-title":"Estimated glomerular filtration rate, albuminuria, and adverse outcomes: an individual-participant data meta-analysis","volume":"330","author":"Writing Group for the CKD Prognosis Consortium","year":"2023","journal-title":"JAMA"},{"key":"2026061813270302000_B6","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/S0140-6736(22)02074-8","article-title":"Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials","volume":"400","author":"Nuffield Department of Population Health Renal Studies Group","year":"2022","journal-title":"Lancet"},{"key":"2026061813270302000_B7","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1080\/1744666X.2025.2537446","article-title":"Advancing kidney protection in type 1 diabetes: insights from emerging therapies in type 2 diabetes and chronic kidney disease","volume":"21","author":"Kugathasan","year":"2025","journal-title":"Expert Rev Clin Immunol"},{"key":"2026061813270302000_B8","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jacc.2019.11.031","article-title":"Mechanisms of cardiorenal effects of sodium-glucose cotransporter 2 inhibitors: JACC state-of-the-art review","volume":"75","author":"Zelniker","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026061813270302000_B9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.31083\/j.fbl2805098","article-title":"SGLT2i in patients with type 1 diabetes: benefits, risks, and preventive strategies","volume":"28","author":"Ma","year":"2023","journal-title":"Front Biosci (Landmark Ed)"},{"key":"2026061813270302000_B10","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.kint.2022.08.012","article-title":"Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"102","author":"de Boer","year":"2022","journal-title":"Kidney Int"},{"key":"2026061813270302000_B11","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.2337\/dc19-0937","article-title":"The impact of sotagliflozin on renal function, albuminuria, blood pressure, and hematocrit in adults with type 1 diabetes","volume":"42","author":"van Raalte","year":"2019","journal-title":"Diabetes Care"},{"key":"2026061813270302000_B12","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.2337\/dc18-1749","article-title":"Empagliflozin as adjunctive to insulin therapy in type 1 diabetes: the EASE trials","volume":"41","author":"Rosenstock","year":"2018","journal-title":"Diabetes Care"},{"key":"2026061813270302000_B13","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.2215\/CJN.07700621","article-title":"Kidney effects of empagliflozin in people with type 1 diabetes","volume":"16","author":"Cherney","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026061813270302000_B14","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.2337\/dc18-0623","article-title":"Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (the DEPICT-2 study): 24-week results from a randomized controlled trial","volume":"41","author":"Mathieu","year":"2018","journal-title":"Diabetes Care"},{"key":"2026061813270302000_B15","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1007\/s00125-023-05975-8","article-title":"SGLT2i and GLP-1 RA therapy in type 1 diabetes and reno-vascular outcomes: a real-world study","volume":"66","author":"Anson","year":"2023","journal-title":"Diabetologia"},{"key":"2026061813270302000_B16","doi-asserted-by":"crossref","first-page":"e1003461","DOI":"10.1371\/journal.pmed.1003461","article-title":"Assessing the risk of ketoacidosis due to sodium-glucose cotransporter (SGLT)-2 inhibitors in patients with type 1 diabetes: a meta-analysis and meta-regression","volume":"17","author":"Musso","year":"2020","journal-title":"PLoS Med"},{"key":"2026061813270302000_B17","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1089\/dia.2023.0605","article-title":"Beta-hydroxybutyrate levels and risk of diabetic ketoacidosis in adults with type 1 diabetes treated with sotagliflozin","volume":"26","author":"Boeder","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"2026061813270302000_B18","first-page":"e1","article-title":"Evaluating cardiovascular benefit of sotagliflozin across kidney and cardiovascular risk in type 1 diabetes: modeling analysis of the inTandem1\u20133 trials","volume":"1","author":"Kugathasan","year":"2026","journal-title":"Diabetes Obes Cardiometab CARE"},{"key":"2026061813270302000_B19","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1007\/s00125-021-05478-4","article-title":"Development and validation of a cardiovascular risk prediction model in type 1 diabetes","volume":"64","author":"McGurnaghan","year":"2021","journal-title":"Diabetologia"},{"key":"2026061813270302000_B20","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S2213-8587(25)00331-6","article-title":"Continuous ketone monitoring for people with diabetes: international expert recommendations on the application of a new technology","volume":"14","author":"Dhatariya","year":"2026","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Diabetes Obesity and Cardiometabolic CARE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/docm-care\/article-pdf\/1\/2\/189\/861007\/docmi250009.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/docm-care\/article-pdf\/1\/2\/189\/861007\/docmi250009.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T17:27:09Z","timestamp":1781803629000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/docm-care\/article\/1\/2\/189\/164671\/Tipping-the-Balance-Maximizing-Cardiovascular"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,1]]},"references-count":20,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,4,8]]},"published-print":{"date-parts":[[2026,3,1]]}},"URL":"https:\/\/doi.org\/10.2337\/doci25-0009","relation":{},"ISSN":["3067-3518","3067-3534"],"issn-type":[{"value":"3067-3518","type":"print"},{"value":"3067-3534","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,1]]}}}